Sensei Biotherapeutics (SNSE) Misses Q3 EPS by 362c

Sensei Biotherapeutics (NASDAQ: SNSE) reported Q3 EPS of ($3.62).

For earnings history and earnings-related data on Sensei Biotherapeutics (SNSE) click here.

You May Also Be Interested In

• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
• BofA says momentum style supported by earnings revisions